FB-401
FB401-02
Phase 2 mab terminated
Quick answer
FB-401 for Atopic Dermatitis is a Phase 2 program (mab) at Forte Biosciences with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Forte Biosciences
- Indication
- Atopic Dermatitis
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated